The grant will support the continuation of the international initiative TOVA – The Onchocerciasis Vaccine for Africa – which was established in 2015 and is comprised of 13 world-renowned scientists and research centers.
The National Institutes of Health-funded Vaccine and Treatment Evaluation Unit at Baylor will be one of the sites for a clinical trial testing the safety and immune responses to a vaccine against chikungunya virus.
Hawaii Biotech, Inc. has been awarded a grant by The National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against infection caused by the mosquito-borne chikungunya virus.
The full pediatric neurological and psychiatric impact of Zika virus infection will take time to sort out and may not be fully realized for years, Dr. Peter Hotez explains in new JAMA Pediatrics editorial.
Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine has identified two important steps to take to prevent the Zika virus from spreading through the Americas.
Dr. Maria Elena Bottazzi, associate dean of the National School of Tropical Medicine and professor of pediatrics at Baylor College of Medicine, is the recipient of the 2015 Jose Cecilio del Valle National Science Award from the government of Honduras.